Hypersensitivity. Hyperthyroidism or any thyroid disease; before & after radioiodine therapy for hyperthyroidism. Do not use 4 wk prior to radioiodine scintigraphy or radioiodine treatment of thyroid carcinoma. Nodular colloid & endemic goiter, Hashimotos thyroiditis. Patients on lithium therapy. Before & after specific medicinal treatment involving the use of radioactive iodine. Pregnancy & lactation. Childn <2 yr.
Spray in a well-ventilated area. Avoid inhaling or spraying into the eyes; pooling beneath the patient in pre-op prep; soln containing a detergent. False +ve results in tests w/ toluidine or gum guaiac for Hb-determination in stool or urine. Discontinue use if skin irritation, contact dermatitis or hypersensitivity occurs. Do not use if conception is desired; on extensive body areas & over a long period of time (>14 days). Do not heat prior to use. Monitor thyroid function up until 3 mth after treatment. Renal impairment.
Rarely, allergic skin reaction (itchiness, redness, small blisters). Very rarely, acute generalized allergic reactions (drop in BP, difficulty in breathing, swelling of the skin & mucosa).
Drug Interactions
May alter the effect w/ concomitant use of other externally applied wound healing drugs/prep. Products containing enzymatic component, alkali, ASA, bismuth, Hg, silver, hydrogen peroxide, tannic acid & taurolidine. May interfere w/ tests on thyroid function. May lead to transient dark discoloration in the areas involved in concomitant or immediately after application of octenidine-containing antiseptics. False +ve results in tests w/ toluidine or gum guaiac for Hb-determination in stool or urine.
Sign Out
